Single vs repeated treatment with the intragastric balloon: A 5-year weight loss study

Obesity Surgery

Volumn 20, Issue 6, 2010, Pages 692-697

  Dumonceau, Jean Marc ^a   François, Erik ^b   Hittelet, Axel ^b   Mehdi, Abdel Ilah ^b   Barea, Marie ^b   Deviere, Jacques ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Gastric balloon; Gastrointestinal endoscopy; Obesity; Weight loss

Indexed keywords

ADULT; ARTICLE; BALLOON; BARIATRIC SURGERY; BODY MASS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; GASTROSCOPY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT DURATION; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GASTRIC BALLOON; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; REOPERATION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 77953230157     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-010-0127-x     Document Type: Article

References (21)

1. JM Dumonceau 2008 Evidence-based review of the bioenterics intragastric balloon for weight loss Obes Surg 18 1611 1617 10.1007/s11695-008-9593-9 18568377
2. A Genco M Cipriano V Bacci, et al. 2006 BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients Int J Obes 30 129 133 10.1038/sj.ijo.0803094 1:STN:280:DC%2BD28%2FntFajsA%3D%3D (Pubitemid 41790788)
3. MA Martinez-Brocca O Belda J Parejo, et al. 2007 Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity Obes Surg 17 649 657 10.1007/s11695-007-9109-z 17658025 (Pubitemid 46945421)
4. EM Mathus-Vliegen GN Tytgat 2005 Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up Gastrointest Endosc 61 19 27 10.1016/S0016-5107(04)02406-X 15672051 (Pubitemid 40169806)
5. National Institutes of Health 1998 Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report Obes Res 6 Suppl 2 51S 209
6. S Zago AM Kornmuller D Agagliati, et al. 2006 Benefit from bio-enteric Intra-gastric balloon (BIB) to modify lifestyle and eating habits in severely obese patients eligible for bariatric surgery Minerva Med 97 51 64 1:STN:280:DC%2BD283nsVaktA%3D%3D 16565699
7. FH Lorentz 1929 Der konstitutionsindex der frau Klin Wochenshr 16 734 736 10.1007/BF01738018
8. SB Doldi G Micheletto MN Perrini, et al. 2002 Treatment of morbid obesity with intragastric balloon in association with diet Obes Surg 12 583 587 10.1381/096089202762252398 1:STN:280:DC%2BD38vjs1Gqtg%3D%3D 12194556
9. G Francica C Giardiello G Iodice, et al. 2004 Ultrasound as the imaging method of choice for monitoring the intragastric balloon in obese patients: normal findings, pitfalls and diagnosis of complications Obes Surg 14 833 837 10.1381/0960892041590791 15318991 (Pubitemid 38982271)
10. JD Douketis C Macie L Thabane, et al. 2005 Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice Int J Obes 29 1153 1167 10.1038/sj.ijo.0802982 1:STN:280:DC%2BD2MvotlOruw%3D%3D (Pubitemid 43080293)
11. ML Dansinger A Tatsioni JB Wong, et al. 2007 Meta-analysis: the effect of dietary counseling for weight loss Ann Intern Med 147 41 50 17606960
12. DM Eddy L Schlessinger R Kahn 2005 Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes Ann Intern Med 143 251 264 16103469
13. E Machytka P Klvana L Hanuskova, et al. 2007 Use of pharmacotherapy for long-term maintenance of weight loss following explantation of intragastric balloon (BIB) Gut 57 A290
14. R Padwal A Kezouh M Levine, et al. 2007 Long-term persistence with orlistat and sibutramine in a population-based cohort Int J Obes 31 1567 1570 10.1038/sj.ijo.0803631 1:CAS:528:DC%2BD2sXhtVyjtrbJ (Pubitemid 47482652)
15. D Rucker R Padwal SK Li C Curioni DC Lau 2007 Long term pharmacotherapy for obesity and overweight: updated meta-analysis BMJ. 337 1194 1199 10.1136/bmj.39385.413113.25 (Pubitemid 350273303)
16. DF Williamson 1999 Pharmacotherapy for obesity JAMA 281 278 280 10.1001/jama.281.3.278 1:STN:280:DyaK1M7hsFSntg%3D%3D 9918485 (Pubitemid 29058119)
17. J Melissas J Mouzas D Filis, et al. 2006 The intragastric balloon-smoothing the path to bariatric surgery Obes Surg 16 897 902 10.1381/096089206777822188 16839490 (Pubitemid 44133480)
18. J Herve CH Wahlen A Schaeken, et al. 2005 What becomes of patients one year after the intragastric balloon has been removed? Obes Surg 15 864 870 10.1381/0960892054222894 1:STN:280:DC%2BD2MzjtVWqtA%3D%3D 15978160 (Pubitemid 40904880)
19. S Roman B Napoleon F Mion, et al. 2004 Intragastric balloon for "non-morbid" obesity: a retrospective evaluation of tolerance and efficacy Obes Surg 14 539 544 10.1381/096089204323013587 15130235 (Pubitemid 38570298)
20. JA Sallet JB Marchesini DS Paiva, et al. 2004 Brazilian multicenter study of the intragastric balloon Obes Surg 14 991 998 10.1381/0960892041719671 15329191 (Pubitemid 39093476)
21. JD Evans MH Scott 2001 Intragastric balloon in the treatment of patients with morbid obesity Br J Surg 88 1245 1248 10.1046/j.0007-1323.2001.01840.x 1:STN:280:DC%2BD3MvovF2jtQ%3D%3D 11531875 (Pubitemid 34015611)